TCL46-07

The Cancer Letter

Inside information on cancer research and drug development

Vol.
46
No.
07
February 14, 2020Feb 14, 2020
DOWNLOAD THE PDF
Sharpless addresses three big issues in cancer in 2020: 1. NCI grantees are prime targets for foreign influence, 2. Treatment seems to drive drop in lung cancer deaths, 3. RPG paylines to rise from 8% to 10%
Cover Story
NCI Director's Report

Sharpless addresses three big issues in cancer in 2020:

1. NCI grantees are prime targets for foreign influence, 2. Treatment seems to drive drop in lung cancer deaths, 3. RPG paylines to rise from 8% to 10%
By Matthew Bin Han Ong
The pace of innovation in oncology has made U.S. cancer researchers prime targets for foreign state-sponsored programs aimed at diverting intellectual property.
Thomas Sellers sues Moffitt, claims defamation
By Matthew Bin Han Ong
Trump's budget proposes slashing NIH, NCI
Free
By Alexandria Carolan
Ohio State expands assistance program to give out previously dispensed cancer drugs
Clinical
By Alexandria Carolan

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account